The future of the global success story of the discovery of small molecule antibiotics, their evolution into viable drug therapies, and their application in ...

Eli Lilly and Co (NYSE:LLY) has entered into a drug discovery collaboration with Insilico Medicine, a clinical-stage ...

The collaboration will focus on advanced therapies, including weight loss.

Lilly licenses Insilico's AI drug discovery platform in a deal worth up to $2.75B, signaling a shift in how novel ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

NJ Bio, Inc. ('NJ Bio'), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma ...

At World ADC London 2026, experts highlighted how advances in payload design, targeting strategies and AI-driven discovery are changing antibody-drug conjugate development.

Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma. Biotech uses AI for breakthrough discovery, while large pharma scales it to ...

Commercial agreement serves as high-profile third party validation of BullFrog AI’s proprietary capabilities Agreement utilizes BullFrog AI’s ...

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 10th Annual Drug Discovery & Development Virtual Event on February ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...